The FDA approved Sunovion Pharmaceuticals' Latuda (lurasidone HCL), an atypical antipsychotic used to treat schizophrenia in adults 18 years and older.
Katelyn Vautrin, PharmD Candidate
Advertisement
Articles by Katelyn Vautrin, PharmD Candidate
Advertisement
Latest Updated Articles
- Sunovion Pharmaceuticals' Latuda
Published: June 13th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
3
Disparities in Continuous Glucose Monitor Prescriptions by Language Preference Among Adults With Type 2 Diabetes
4
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
5
